Ser96Ala genetic variant of the human histidine-rich calcium-binding protein is a genetic predictor of recurrence after catheter ablation in patients with paroxysmal atrial fibrillation.

BACKGROUND:Atrial fibrillation (AF) recurrence after radiofrequency catheter ablation (RFCA) still remains a serious issue. Ca2+ handling has a considerable effect on AF recurrence. The histidine-rich calcium-binding protein (HRC) genetic single nucleotide polymorphism (SNP), rs3745297 (T>G, Ser9...

Full description

Bibliographic Details
Main Authors: Michitaka Amioka, Yukiko Nakano, Hidenori Ochi, Yuko Onohara, Akinori Sairaku, Takehito Tokuyama, Chikaaki Motoda, Hiroya Matsumura, Shunsuke Tomomori, Naoya Hironobe, Yousaku Okubo, Sho Okamura, Kazuaki Chayama, Yasuki Kihara
Format: Article
Language:English
Published: Public Library of Science (PLoS) 2019-01-01
Series:PLoS ONE
Online Access:https://doi.org/10.1371/journal.pone.0213208
id doaj-9c1ae919e3874c8db5127d5552f12154
record_format Article
spelling doaj-9c1ae919e3874c8db5127d5552f121542021-03-03T20:50:15ZengPublic Library of Science (PLoS)PLoS ONE1932-62032019-01-01143e021320810.1371/journal.pone.0213208Ser96Ala genetic variant of the human histidine-rich calcium-binding protein is a genetic predictor of recurrence after catheter ablation in patients with paroxysmal atrial fibrillation.Michitaka AmiokaYukiko NakanoHidenori OchiYuko OnoharaAkinori SairakuTakehito TokuyamaChikaaki MotodaHiroya MatsumuraShunsuke TomomoriNaoya HironobeYousaku OkuboSho OkamuraKazuaki ChayamaYasuki KiharaBACKGROUND:Atrial fibrillation (AF) recurrence after radiofrequency catheter ablation (RFCA) still remains a serious issue. Ca2+ handling has a considerable effect on AF recurrence. The histidine-rich calcium-binding protein (HRC) genetic single nucleotide polymorphism (SNP), rs3745297 (T>G, Ser96Ala), is known to cause a sarcoplasmic reticulum Ca2+ leak. We investigated the association between HRC Ser96Ala and AF recurrence after RFCA in paroxysmal AF (PAF) patients. METHODS AND RESULTS:We enrolled PAF patients who underwent RFCA (N = 334 for screening and N = 245 for replication) and were genotyped for HRC SNP (rs3745297). The patient age was younger and rate of diabetes and hypertension lower in the PAF patients with Ser96Ala than in those without (TT/TG/GG, 179/120/35; 64±10/60±12/59±13 y, P = 0.001; 18.5/ 9.2/8.6%, P = 0.04 and 66.1/50.0/37.1%, P = 0.001, respectively). During a mean 19 month follow-up, 57 (17.1%) patients suffered from AF recurrences. The rate of an Ser96Ala was significantly higher in patients with AF recurrence than in those without in the screening set (allele frequency model: odds ratio [OR], 1.80; P = 0.006). We also confirmed this significant association in the replication set (OR 1.74; P = 0.03) and combination (P = 0.0008). A multivariate analysis revealed that the AF duration, sinus node dysfunction, and HRC Ser96Ala were independent predictors of an AF recurrence (hazard ratio [HR], 1.04, P = 0.037; HR 2.42, P = 0.018; and HR 2.66, P = 0.007, respectively). CONCLUSION:HRC SNP Ser96Ala is important as a new genetic marker of AF recurrence after RFCA.https://doi.org/10.1371/journal.pone.0213208
collection DOAJ
language English
format Article
sources DOAJ
author Michitaka Amioka
Yukiko Nakano
Hidenori Ochi
Yuko Onohara
Akinori Sairaku
Takehito Tokuyama
Chikaaki Motoda
Hiroya Matsumura
Shunsuke Tomomori
Naoya Hironobe
Yousaku Okubo
Sho Okamura
Kazuaki Chayama
Yasuki Kihara
spellingShingle Michitaka Amioka
Yukiko Nakano
Hidenori Ochi
Yuko Onohara
Akinori Sairaku
Takehito Tokuyama
Chikaaki Motoda
Hiroya Matsumura
Shunsuke Tomomori
Naoya Hironobe
Yousaku Okubo
Sho Okamura
Kazuaki Chayama
Yasuki Kihara
Ser96Ala genetic variant of the human histidine-rich calcium-binding protein is a genetic predictor of recurrence after catheter ablation in patients with paroxysmal atrial fibrillation.
PLoS ONE
author_facet Michitaka Amioka
Yukiko Nakano
Hidenori Ochi
Yuko Onohara
Akinori Sairaku
Takehito Tokuyama
Chikaaki Motoda
Hiroya Matsumura
Shunsuke Tomomori
Naoya Hironobe
Yousaku Okubo
Sho Okamura
Kazuaki Chayama
Yasuki Kihara
author_sort Michitaka Amioka
title Ser96Ala genetic variant of the human histidine-rich calcium-binding protein is a genetic predictor of recurrence after catheter ablation in patients with paroxysmal atrial fibrillation.
title_short Ser96Ala genetic variant of the human histidine-rich calcium-binding protein is a genetic predictor of recurrence after catheter ablation in patients with paroxysmal atrial fibrillation.
title_full Ser96Ala genetic variant of the human histidine-rich calcium-binding protein is a genetic predictor of recurrence after catheter ablation in patients with paroxysmal atrial fibrillation.
title_fullStr Ser96Ala genetic variant of the human histidine-rich calcium-binding protein is a genetic predictor of recurrence after catheter ablation in patients with paroxysmal atrial fibrillation.
title_full_unstemmed Ser96Ala genetic variant of the human histidine-rich calcium-binding protein is a genetic predictor of recurrence after catheter ablation in patients with paroxysmal atrial fibrillation.
title_sort ser96ala genetic variant of the human histidine-rich calcium-binding protein is a genetic predictor of recurrence after catheter ablation in patients with paroxysmal atrial fibrillation.
publisher Public Library of Science (PLoS)
series PLoS ONE
issn 1932-6203
publishDate 2019-01-01
description BACKGROUND:Atrial fibrillation (AF) recurrence after radiofrequency catheter ablation (RFCA) still remains a serious issue. Ca2+ handling has a considerable effect on AF recurrence. The histidine-rich calcium-binding protein (HRC) genetic single nucleotide polymorphism (SNP), rs3745297 (T>G, Ser96Ala), is known to cause a sarcoplasmic reticulum Ca2+ leak. We investigated the association between HRC Ser96Ala and AF recurrence after RFCA in paroxysmal AF (PAF) patients. METHODS AND RESULTS:We enrolled PAF patients who underwent RFCA (N = 334 for screening and N = 245 for replication) and were genotyped for HRC SNP (rs3745297). The patient age was younger and rate of diabetes and hypertension lower in the PAF patients with Ser96Ala than in those without (TT/TG/GG, 179/120/35; 64±10/60±12/59±13 y, P = 0.001; 18.5/ 9.2/8.6%, P = 0.04 and 66.1/50.0/37.1%, P = 0.001, respectively). During a mean 19 month follow-up, 57 (17.1%) patients suffered from AF recurrences. The rate of an Ser96Ala was significantly higher in patients with AF recurrence than in those without in the screening set (allele frequency model: odds ratio [OR], 1.80; P = 0.006). We also confirmed this significant association in the replication set (OR 1.74; P = 0.03) and combination (P = 0.0008). A multivariate analysis revealed that the AF duration, sinus node dysfunction, and HRC Ser96Ala were independent predictors of an AF recurrence (hazard ratio [HR], 1.04, P = 0.037; HR 2.42, P = 0.018; and HR 2.66, P = 0.007, respectively). CONCLUSION:HRC SNP Ser96Ala is important as a new genetic marker of AF recurrence after RFCA.
url https://doi.org/10.1371/journal.pone.0213208
work_keys_str_mv AT michitakaamioka ser96alageneticvariantofthehumanhistidinerichcalciumbindingproteinisageneticpredictorofrecurrenceaftercatheterablationinpatientswithparoxysmalatrialfibrillation
AT yukikonakano ser96alageneticvariantofthehumanhistidinerichcalciumbindingproteinisageneticpredictorofrecurrenceaftercatheterablationinpatientswithparoxysmalatrialfibrillation
AT hidenoriochi ser96alageneticvariantofthehumanhistidinerichcalciumbindingproteinisageneticpredictorofrecurrenceaftercatheterablationinpatientswithparoxysmalatrialfibrillation
AT yukoonohara ser96alageneticvariantofthehumanhistidinerichcalciumbindingproteinisageneticpredictorofrecurrenceaftercatheterablationinpatientswithparoxysmalatrialfibrillation
AT akinorisairaku ser96alageneticvariantofthehumanhistidinerichcalciumbindingproteinisageneticpredictorofrecurrenceaftercatheterablationinpatientswithparoxysmalatrialfibrillation
AT takehitotokuyama ser96alageneticvariantofthehumanhistidinerichcalciumbindingproteinisageneticpredictorofrecurrenceaftercatheterablationinpatientswithparoxysmalatrialfibrillation
AT chikaakimotoda ser96alageneticvariantofthehumanhistidinerichcalciumbindingproteinisageneticpredictorofrecurrenceaftercatheterablationinpatientswithparoxysmalatrialfibrillation
AT hiroyamatsumura ser96alageneticvariantofthehumanhistidinerichcalciumbindingproteinisageneticpredictorofrecurrenceaftercatheterablationinpatientswithparoxysmalatrialfibrillation
AT shunsuketomomori ser96alageneticvariantofthehumanhistidinerichcalciumbindingproteinisageneticpredictorofrecurrenceaftercatheterablationinpatientswithparoxysmalatrialfibrillation
AT naoyahironobe ser96alageneticvariantofthehumanhistidinerichcalciumbindingproteinisageneticpredictorofrecurrenceaftercatheterablationinpatientswithparoxysmalatrialfibrillation
AT yousakuokubo ser96alageneticvariantofthehumanhistidinerichcalciumbindingproteinisageneticpredictorofrecurrenceaftercatheterablationinpatientswithparoxysmalatrialfibrillation
AT shookamura ser96alageneticvariantofthehumanhistidinerichcalciumbindingproteinisageneticpredictorofrecurrenceaftercatheterablationinpatientswithparoxysmalatrialfibrillation
AT kazuakichayama ser96alageneticvariantofthehumanhistidinerichcalciumbindingproteinisageneticpredictorofrecurrenceaftercatheterablationinpatientswithparoxysmalatrialfibrillation
AT yasukikihara ser96alageneticvariantofthehumanhistidinerichcalciumbindingproteinisageneticpredictorofrecurrenceaftercatheterablationinpatientswithparoxysmalatrialfibrillation
_version_ 1714820273910317056